Paul Moraviec (born April 1958)[1] is a British businessman. He was the chief executive officer (CEO) of Convatec, an international medical products and technologies company, listed on the FTSE 100 Index, from April 2015 to October 2018.[2]

Paul Moraviec
BornApril 1958 (age 66)
NationalityBritish
EducationKingston University
OccupationBusinessman
TitleCEO, Convatec
TermApril 2015-October 2018

Early life

edit

Moraviec has a master's degree in marketing from London's Kingston University Business School.[3]

Career

edit

Before joining Convatec, he was vice president, neurosurgery business at Johnson & Johnson, and vice president, international commercialoperations at Abbott Laboratories.[4]

Convatec announced that Moraviec will be retiring with immediate effect on 15 October 2018, and will be succeeded on an interim basis by non-executive director Rick Anderson, who was formerly the chairman of Johnson & Johnson.[5]

References

edit
  1. ^ "Paul MORAVIEC - Personal Appointments (free information from Companies House)". Beta.companieshouse.gov.uk. Retrieved 18 December 2016.
  2. ^ "ConvaTec Appoints Paul Moraviec CEO Effective April 30, 2015". Convatec.co.uk. 30 April 2015. Retrieved 18 December 2016.
  3. ^ Paul Moraviec (22 December 2014). "Paul Moraviec: Executive Profile & Biography". Bloomberg. Retrieved 18 December 2016.
  4. ^ "Paul Moraviec". The Wall Street Journal.
  5. ^ "Paul Moraviec". Convatec.